• This record comes from PubMed

Tailored Multivalent Neo-Glycoproteins: Synthesis, Evaluation, and Application of a Library of Galectin-3-Binding Glycan Ligands

. 2017 Nov 15 ; 28 (11) : 2832-2840. [epub] 20171018

Language English Country United States Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Galectin-3 (Gal-3), a member of the β-galactoside-binding lectin family, is a tumor biomarker and involved in tumor angiogenesis and metastasis. Gal-3 is therefore considered as a promising target for early cancer diagnosis and anticancer therapy. We here present the synthesis of a library of tailored multivalent neo-glycoproteins and evaluate their Gal-3 binding properties. By the combinatorial use of glycosyltransferases and chemo-enzymatic reactions, we first synthesized a set of N-acetyllactosamine (Galβ1,4GlcNAc; LacNAc type 2)-based oligosaccharides featuring five different terminating glycosylation epitopes, respectively. Neo-glycosylation of bovine serum albumin (BSA) was accomplished by dialkyl squarate coupling to lysine residues resulting in a library of defined multivalent neo-glycoproteins. Solid-phase binding assays with immobilized neo-glycoproteins revealed distinct affinity and specificity of the multivalent glycan epitopes for Gal-3 binding. In particular, neo-glycoproteins decorated with N',N″-diacetyllactosamine (GalNAcβ1,4GlcNAc; LacdiNAc) epitopes showed high selectivity and were demonstrated to capture Gal-3 from human serum with high affinity. Furthermore, neo-glycoproteins with terminal biotinylated LacNAc glycan motif could be utilized as Gal-3 detection agents in a sandwich enzyme-linked immunosorbent assay format. We conclude that, in contrast to antibody-based capture steps, the presented neo-glycoproteins are highly useful to detect functionally intact Gal-3 with high selectivity and avidity. We further gain novel insights into the binding affinity of Gal-3 using tailored multivalent neo-glycoproteins, which have the potential for an application in the context of cancer-related biomedical research.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

Selective Glycopolymer Inhibitors of Galectin-3: Supportive Anti-Cancer Agents Protecting Monocytes and Preserving Interferon-Gamma Function

. 2025 ; 20 () : 6591-6609. [epub] 20250524

Glycopolymer Inhibitors of Galectin-3 Suppress the Markers of Tissue Remodeling in Pulmonary Hypertension

. 2024 Jun 13 ; 67 (11) : 9214-9226. [epub] 20240603

Oligosaccharide Ligands of Galectin-4 and Its Subunits: Multivalency Scores Highly

. 2023 May 11 ; 28 (10) : . [epub] 20230511

Cross-Linking Effects Dictate the Preference of Galectins to Bind LacNAc-Decorated HPMA Copolymers

. 2021 Jun 01 ; 22 (11) : . [epub] 20210601

Interaction between Galectin-3 and Integrins Mediates Cell-Matrix Adhesion in Endothelial Cells and Mesenchymal Stem Cells

. 2021 May 13 ; 22 (10) : . [epub] 20210513

The β-N-Acetylhexosaminidase in the Synthesis of Bioactive Glycans: Protein and Reaction Engineering

. 2019 Feb 08 ; 24 (3) : . [epub] 20190208

Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3

. 2018 Sep 20 ; 16 (1) : 73. [epub] 20180920

Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling

. 2018 Jan 26 ; 19 (2) : . [epub] 20180126

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...